William A. Lumpkin is an acquisition entrepreneur dedicated to finding and scaling a business with deep, local community impact.

Most recently Head of New Product Strategy and Business Development at Alexion - AstraZeneca Rare Disease, he has consistently exceeded expectations in accelerating global billion-dollar brands across the biotech, consumer packaged goods, medical device, and rare disease industries. Prior to Alexion, William held a diverse set of U.S. and global commercial leadership roles at Takeda, Baxter, Baxalta, Shire, and Procter & Gamble spanning functional disciplines, product lifecycles and therapeutic areas.

Passionate about training and developing others, William was on faculty at the Kenan Flagler School of Business, University of North Carolina in addition to his full-time corporate leadership roles. He is intentional about creating a positive work environment, delivering commitments and coaching people to meet their individual potential. William understands how important it is for colleagues to feel heard, included, and valued.

William is also a seasoned investor having founded, acquired, and exited businesses including a multi-bay and automatic car wash, a commercial concrete and excavation business, and a cold storage and distribution business. He has also executed residential and commercial real estate development projects across multiple states.

He has an MBA from the University of Chicago Booth School of Business and Bachelor of Science in Finance from Indiana University (where he was a 4x letterman and an elected football captain). Originally from Dayton, Ohio, William is a proud father of three (Ailey, Sage, and William) and lives with his wife (Layla) in Houston, TX.